E
Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management, make us your ideal partner for all of your radiopharmaceutical development, manufacturing, and commercialization needs.
Investor insights
Funding rounds participated in
$26M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Date founded
2019
Funding rounds raised
Total raised
$26M
from 3 investors over 1 rounds
E
Evergreen Theragnostics raised $26M on May 16, 2024
Investors: Petrichor Healthcare Capital Management, LIFTT and + 1 Other investor